Antiemetics
Ref: 4Z-A-3237
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Fosaprepitant Impurity 10
CAS:265121-04-8
Formula:
C23H22F7N4O7P
Color and Shape:
White To Off-White Solid
Molecular weight:
630.42
Ref: 4Z-F-3617
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Fosaprepitant Impurity 45
Formula:
C23H22F7N4O6P
Color and Shape:
White To Off-White Solid
Molecular weight:
614.41
Ref: 4Z-F-3653
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-A-3249
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-N-075032
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Fosaprepitant dimeglumine
CAS:265121-04-8
Fosaprepitant dimeglumine (MK-0517) is a soluble prodrug of aprepitant, which prevents nausea by blocking NK1 …
Formula:
C37H56F7N6O16P
Purity:
97.39% - 98.75%
Color and Shape:
Solid
Molecular weight:
1004.83
Ref: TM-T1790
5mg | 49.00 € | ||
10mg | 66.00 € | ||
25mg | 119.00 € | ||
50mg | 208.00 € | ||
100mg | 343.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3630
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-N-075031
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3623
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3643
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3634
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3655
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-N-075030
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-N-075033
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Aprepitant
CAS:170729-80-3
Aprepitant (Aprepitant') is a Substance P/Neurokinin-1 Receptor Antagonist.
Formula:
C23H21F7N4O3
Purity:
98% - 99.9%
Color and Shape:
Off-White To Light Yellow Cyrstalline Solid
Molecular weight:
534.43
Ref: TM-T1743
5mg | 57.00 € | ||
10mg | 68.00 € | ||
50mg | 92.00 € | ||
100mg | 100.00 € | ||
200mg | 119.00 € | ||
500mg | 148.00 € | ||
1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3662
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3639
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3660
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-A-3243
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024
Ref: 4Z-F-3657
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Friday 22 Nov 2024